Validation pour Ingenuity228

vers la météo de la validation par utilisateur

Ingenuity228

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 20 - PMID ?

In fibroblasts from SP skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of SP NODE that is increased by deprivation of serum .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A1">Analyse 1

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A2">Analyse 2

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A3">Analyse 3

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A4">Analyse 4

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                          |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A5">Analyse 5

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A6">Analyse 6

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A7">Analyse 7

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A8">Analyse 8

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A9">Analyse 9

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A10">Analyse 10

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A11">Analyse 11

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                  |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A12">Analyse 12

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A13">Analyse 13

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A14">Analyse 14

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A15">Analyse 15

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |           +-------------------------OBJ:V-N------------------------+                              
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         |           |                   +--------------SUBJ:V-N--------------+                              
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         |           |                   +----COMP:N-N(of)---+                |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         +COMP:V-N(by+  +MOD_+MOD_ATT:N-N+           +MOD_ATT+                +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |  |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,@card@)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (expression,percent)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,@card@)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A16">Analyse 16

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+           +-------------------------OBJ:V-N------------------------+                              
         |                    |                |             +-----------------OBJ:V-N----------------+                     |           |                   +--------------SUBJ:V-N--------------+                              
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         |           |                   +-----------SUBJ:V-N-----------+     |                              
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         |           |                   +----COMP:N-N(of)---+          |     |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         +COMP:V-N(by+  +MOD_+MOD_ATT:N-N+           +MOD_ATT+          |     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |  |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,@card@)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (expression,percent)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,@card@)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A17">Analyse 17

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |           +-------------------------OBJ:V-N------------------------+                              
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         |           |                   +--------------SUBJ:V-N--------------+                              
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         |           |                   +----COMP:N-N(of)---+                |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         +COMP:V-N(by+  +MOD_+MOD_ATT:N-N+           +MOD_ATT+                +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |  |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,@card@)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (expression,percent)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,@card@)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A18">Analyse 18

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |           +-------------------------OBJ:V-N------------------------+                              
         |                    |                              |                  +-----------COMP:N-N(of)----------+         |           |                   +--------------SUBJ:V-N--------------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         |           |                   +----COMP:N-N(of)---+                |                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         +COMP:V-N(by+  +MOD_+MOD_ATT:N-N+           +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |  |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,@card@)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (expression,percent)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,@card@)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A19">Analyse 19

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |           +-------------------------OBJ:V-N------------------------+                              
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         |           |                   +--------------SUBJ:V-N--------------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         |           |                   +----COMP:N-N(of)---+                |                              
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         +COMP:V-N(by+  +MOD_+MOD_ATT:N-N+           +MOD_ATT+                +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |  |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,@card@)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (expression,percent)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,@card@)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A20">Analyse 20

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+           +-------------------------OBJ:V-N------------------------+                              
         |                    |                              +-----------------OBJ:V-N----------------+                     |           |                   +--------------SUBJ:V-N--------------+                              
         |                    |                              |                  +-----------COMP:N-N(of)----------+         |           |                   +-----------SUBJ:V-N-----------+     |                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         |           |                   +----COMP:N-N(of)---+          |     |                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         +COMP:V-N(by+  +MOD_+MOD_ATT:N-N+           +MOD_ATT+          |     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |  |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,@card@)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (expression,percent)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,@card@)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A21">Analyse 21

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |           +-------------------------OBJ:V-N------------------------+                              
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         |           |                   +--------------SUBJ:V-N--------------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         |           |                   +----COMP:N-N(of)---+                |                              
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         +COMP:V-N(by+  +MOD_+MOD_ATT:N-N+           +MOD_ATT+                +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |  |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,@card@)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (expression,percent)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,@card@)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A22">Analyse 22

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A23">Analyse 23

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A24">Analyse 24

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A25">Analyse 25

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A26">Analyse 26

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A27">Analyse 27

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A28">Analyse 28

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A29">Analyse 29

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A30">Analyse 30

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A31">Analyse 31

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A32">Analyse 32

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A33">Analyse 33

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A34">Analyse 34

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A35">Analyse 35

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A36">Analyse 36

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A37">Analyse 37

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A38">Analyse 38

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A39">Analyse 39

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A40">Analyse 40

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A41">Analyse 41

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A42">Analyse 42

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A43">Analyse 43

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A44">Analyse 44

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A45">Analyse 45

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A46">Analyse 46

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A47">Analyse 47

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A48">Analyse 48

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A49">Analyse 49

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A50">Analyse 50

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A51">Analyse 51

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A52">Analyse 52

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A53">Analyse 53

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A54">Analyse 54

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A55">Analyse 55

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A56">Analyse 56

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A57">Analyse 57

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A58">Analyse 58

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A59">Analyse 59

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A60">Analyse 60

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                              
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A61">Analyse 61

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+                              
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A62">Analyse 62

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A63">Analyse 63

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A64">Analyse 64

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A65">Analyse 65

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A66">Analyse 66

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A67">Analyse 67

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A68">Analyse 68

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A69">Analyse 69

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A70">Analyse 70

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                              
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A71">Analyse 71

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A72">Analyse 72

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A73">Analyse 73

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A74">Analyse 74

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A75">Analyse 75

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A76">Analyse 76

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+                              
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A77">Analyse 77

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+                              
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A78">Analyse 78

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A79">Analyse 79

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A80">Analyse 80

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A81">Analyse 81

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A82">Analyse 82

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A83">Analyse 83

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A84">Analyse 84

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A85">Analyse 85

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A86">Analyse 86

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A87">Analyse 87

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A88">Analyse 88

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A89">Analyse 89

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A90">Analyse 90

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A91">Analyse 91

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A92">Analyse 92

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A93">Analyse 93

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A94">Analyse 94

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A95">Analyse 95

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A96">Analyse 96

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A97">Analyse 97

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A98">Analyse 98

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A99">Analyse 99

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                              
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A100">Analyse 100

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A101">Analyse 101

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                              
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A102">Analyse 102

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+---------------OBJ:V-N--------------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+                              
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A103">Analyse 103

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A104">Analyse 104

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A105">Analyse 105

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A106">Analyse 106

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A107">Analyse 107

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A108">Analyse 108

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A109">Analyse 109

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A110">Analyse 110

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A111">Analyse 111

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A112">Analyse 112

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A113">Analyse 113

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A114">Analyse 114

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A115">Analyse 115

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                  |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A116">Analyse 116

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A117">Analyse 117

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A118">Analyse 118

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A119">Analyse 119

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A120">Analyse 120

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A121">Analyse 121

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                              
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A122">Analyse 122

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A123">Analyse 123

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                               
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A124">Analyse 124

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A125">Analyse 125

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A126">Analyse 126

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A127">Analyse 127

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                         |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A128">Analyse 128

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A129">Analyse 129

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A130">Analyse 130

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A131">Analyse 131

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                         |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A132">Analyse 132

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+                         |    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |                         |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+          |     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A133">Analyse 133

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A134">Analyse 134

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A135">Analyse 135

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                          |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A136">Analyse 136

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A137">Analyse 137

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A138">Analyse 138

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A139">Analyse 139

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A140">Analyse 140

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+                              
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |                              
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A141">Analyse 141

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+                              
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A142">Analyse 142

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A143">Analyse 143

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                              
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                              
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A144">Analyse 144

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A145">Analyse 145

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A146">Analyse 146

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                  |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A147">Analyse 147

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A148">Analyse 148

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A149">Analyse 149

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |                         |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     +COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A150">Analyse 150

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+                         |    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A151">Analyse 151

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A152">Analyse 152

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A153">Analyse 153

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A154">Analyse 154

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A155">Analyse 155

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A156">Analyse 156

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A157">Analyse 157

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                          |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A158">Analyse 158

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                              
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A159">Analyse 159

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +------------SUBJ:V_PASS-N-----------+                              
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |                              
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |                              
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+          |     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A160">Analyse 160

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                  |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A161">Analyse 161

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A162">Analyse 162

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                  |                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A163">Analyse 163

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A164">Analyse 164

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                                          |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A165">Analyse 165

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A166">Analyse 166

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +------------SUBJ:V_PASS-N-----------+                              
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |                              
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |                              
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+          |     +COMP:V_PASS-N+COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A167">Analyse 167

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                         |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A168">Analyse 168

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                  |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A169">Analyse 169

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                                                  |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A170">Analyse 170

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A171">Analyse 171

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A172">Analyse 172

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+                         |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                +COMP:V_PASS-N+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,deprivation)

name="reponse" value="A173">Analyse 173

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A174">Analyse 174

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+                
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+          |     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,deprivation)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A175">Analyse 175

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A176">Analyse 176

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                   +---------------COMP:N-N(of)---------------+    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A177">Analyse 177

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A178">Analyse 178

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                           +-------------------COMP:N-N(of)-------------------+    
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                         |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A179">Analyse 179

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------------COMP:N-N(of)-------------------+    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A180">Analyse 180

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A181">Analyse 181

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A182">Analyse 182

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                                                                   
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A183">Analyse 183

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A184">Analyse 184

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A185">Analyse 185

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+                         |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A186">Analyse 186

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+             |                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+          |     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A187">Analyse 187

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+             |                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+          |     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A188">Analyse 188

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A189">Analyse 189

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A190">Analyse 190

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A191">Analyse 191

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A192">Analyse 192

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A193">Analyse 193

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                           +-------------------COMP:N-N(of)-------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                         |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A194">Analyse 194

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------------COMP:N-N(of)-------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                         |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A195">Analyse 195

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------------COMP:N-N(of)-------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+                         |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A196">Analyse 196

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                   +---------------COMP:N-N(of)---------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A197">Analyse 197

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                   +---------------COMP:N-N(of)---------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A198">Analyse 198

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A199">Analyse 199

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A200">Analyse 200

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A201">Analyse 201

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A202">Analyse 202

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A203">Analyse 203

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A204">Analyse 204

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A205">Analyse 205

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+             |           |    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+          |     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A206">Analyse 206

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A207">Analyse 207

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A208">Analyse 208

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A209">Analyse 209

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A210">Analyse 210

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A211">Analyse 211

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A212">Analyse 212

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A213">Analyse 213

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A214">Analyse 214

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A215">Analyse 215

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A216">Analyse 216

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                   +---------------COMP:N-N(of)---------------+    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A217">Analyse 217

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A218">Analyse 218

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A219">Analyse 219

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+                         |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A220">Analyse 220

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A221">Analyse 221

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A222">Analyse 222

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                              |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A223">Analyse 223

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                           +-------------------COMP:N-N(of)-------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+                         |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+                         |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (__SP__,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A224">Analyse 224

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                   +---------------COMP:N-N(of)---------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+                   +---------COMP:N-N(by)---------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
COMP:N-N(of) (__NODE__,serum)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A225">Analyse 225

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+---------COMP:N-N(by)---------+           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+--SUBJ:V_PASS-N-+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,deprivation)
SUBJ:V_PASS-N (increase,__NODE__)

name="reponse" value="A226">Analyse 226

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A227">Analyse 227

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+---------------OBJ:V-N--------------+                         |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+                         |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     +-COMP:V-N(by)+           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,deprivation)

name="reponse" value="A228">Analyse 228

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A229">Analyse 229

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           |           +MOD_ATT+                |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A230">Analyse 230

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +------------SUBJ:V_PASS-N-----------+             |                
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A231">Analyse 231

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A232">Analyse 232

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+     |             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+          |     |             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+          |     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A233">Analyse 233

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +----COMP:N-N(of)---+                |             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           |           +MOD_ATT+                |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

name="reponse" value="A234">Analyse 234

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A235">Analyse 235

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                           +-------------------COMP:N-N(of)-------------------+    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
COMP:N-N(of) (__SP__,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A236">Analyse 236

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A237">Analyse 237

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A238">Analyse 238

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                           +-------------------COMP:N-N(of)-------------------+    
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                           +-------------COMP:N-N(by)-------------+           |    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
COMP:N-N(of) (__SP__,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A239">Analyse 239

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                                     |             +-----------------OBJ:V-N----------------+                     |                                           +-------------------COMP:N-N(of)-------------------+    
         |                                     |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+           |    
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
COMP:N-N(of) (__SP__,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A240">Analyse 240

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                           +-------------COMP:N-N(by)-------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A241">Analyse 241

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A242">Analyse 242

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                                                                                   
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A243">Analyse 243

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                           +-------------COMP:N-N(by)-------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |                
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A244">Analyse 244

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                                                                                                   
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+           |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
COMP:N-N(by) (__SP__,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A245">Analyse 245

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                                           +-------------------COMP:N-N(of)-------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
COMP:N-N(of) (__SP__,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A246">Analyse 246

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |                
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |                
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A247">Analyse 247

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+                
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A248">Analyse 248

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |           |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A249">Analyse 249

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                           +-------------------COMP:N-N(of)-------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                                           +-------------COMP:N-N(by)-------------+           |    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
COMP:N-N(of) (__SP__,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A250">Analyse 250

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
COMP:N-N(by) (__SP__,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A251">Analyse 251

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                |             |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |           |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A252">Analyse 252

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               |           +-------------COMP:N-N(by)-------------+           |    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
COMP:N-N(by) (__SP__,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A253">Analyse 253

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A254">Analyse 254

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     |                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              |                  +-----------COMP:N-N(of)----------+         +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
COMP:N-N(of) (mg/l,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A255">Analyse 255

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                                     +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------COMP:N-N(by)-------------------+                
         |                                     |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |                
         +---COMP:N-N(from)---+                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |                
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             +COMP:N-N(of+    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,skin)
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A256">Analyse 256

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                           +-------------------COMP:N-N(of)-------------------+    
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                           +-------------COMP:N-N(by)-------------+           |    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
COMP:N-N(of) (__SP__,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A257">Analyse 257

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                                           +-------------------COMP:N-N(of)-------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,deprivation)
COMP:N-N(of) (__SP__,serum)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A258">Analyse 258

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A259">Analyse 259

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +-------------COMP:N-N(by)-------------+           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           +---------OBJ:V-N--------+             |           |    
         +COMP:N-N(from)+     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
COMP:N-N(by) (__SP__,deprivation)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A260">Analyse 260

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                                                                                                   
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+                
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |                
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             +COMP:N-N(of+    
         |              |     |     |                        |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:N-N(of) (deprivation,serum)

name="reponse" value="A261">Analyse 261

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |                    +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                   
         |                    |                +----------------------------------SUBJ:V-N----------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    |                |             +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |                    |                |             +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |           |    
         |              +MOD_A+                |             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
MOD_ATT:N-ADJ (skin,__SP__)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,skin)
SUBJ:V-N (decrease,hydroxycholesterol)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A262">Analyse 262

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               |           +-------------COMP:N-N(by)-------------+           |    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
COMP:N-N(by) (__SP__,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A263">Analyse 263

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               |           +-------------COMP:N-N(by)-------------+           |    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+           +---------OBJ:V-N--------+             |           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |           |       +----SUBJ:V-N----+             |           |    
         |              |     +------APPOS-----+             |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |           +MOD_ATT+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |                |             |       |      |   |            |        |       |   |         |           |       |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,hydroxycholesterol)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(of) (expression,serum)
COMP:N-N(by) (__SP__,deprivation)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A264">Analyse 264

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |                    +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------COMP:N-N(by)-------------------+           |    
         |                    |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+---------------OBJ:V-N--------------+             |           |    
         |                    |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           |                   +----SUBJ:V-N----+             |           |    
         +COMP:N-N(from)+     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +-SUBJ:V-N-+     |             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |          |     |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
COMP:N-N(from) (fibroblast,__SP__)
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

name="reponse" value="A265">Analyse 265

         +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                   
         |              +-------------------------------------------COMP:V-N(from)------------------------------------------+                                                                                                   
         |              |     +-------------------------------------------SUBJ:V-N------------------------------------------+                               +-------------------------COMP:N-N(of)-------------------------+    
         |              |     |                              +-----------------OBJ:V-N----------------+                     +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+           |    
         |              |     |                              +------OBJ:V-N-----+                     +COMP:N-N(of+         +----COMP:V-N(by)---+           +---------------OBJ:V-N--------------+             |           |    
         |              |     +APPOS+                        |       +COMP:N+   |            +MOD_ATT:+       +MOD+         |              +MOD_+           +COMP:N-N(of+       +----SUBJ:V-N----+             |           |    
         |              |     |     |                        |       |      |   |            |        |       |   |         |              |    |           |           |       |                |             |           |    
 In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum .
APPOS (skin,@card@)
OBJ:V-N (with,mg/l)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,5)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,fibroblast)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,skin)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,deprivation)
COMP:N-N(of) (expression,serum)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)